Cellebrite DI Sees Q3 Sales $121.000M-$126.000M vs $124.357M Est
Benzinga Newsdesk 1 year ago
NewsGuidance
Cellebrite DI (NASDAQ:CLBT) sees Q3 sales of $121.000 million-$126.000 million vs $124.357 million analyst estimate.
Cellebrite DI (NASDAQ:CLBT) sees Q3 sales of $121.000 million-$126.000 million vs $124.357 million analyst estimate.